0
0

Ensuring Sufficient Supply of Testing Act

2/5/2024, 2:30 PM

Summary of Bill HR 3840

Bill 118 hr 3840, also known as the Ensuring Sufficient Supply of Testing Act, is a piece of legislation introduced in the US Congress with the goal of ensuring that there is an adequate supply of testing materials and resources available for COVID-19 testing.

The bill aims to address the ongoing challenges faced by healthcare providers and public health agencies in obtaining the necessary testing supplies to effectively test for the coronavirus. It seeks to increase the production and distribution of testing materials, such as swabs, reagents, and personal protective equipment, to meet the growing demand for testing across the country.

Additionally, the Ensuring Sufficient Supply of Testing Act includes provisions to improve coordination between federal, state, and local agencies in the procurement and distribution of testing supplies. It also calls for increased transparency in reporting on testing supply levels and distribution to ensure that resources are allocated efficiently and effectively. Overall, the bill is designed to enhance the nation's ability to conduct widespread testing for COVID-19, which is crucial for controlling the spread of the virus and protecting public health. It is currently being reviewed by Congress and has garnered bipartisan support for its efforts to address the testing supply shortages that have been a major obstacle in the fight against the pandemic.

Current Status of Bill HR 3840

Bill HR 3840 is currently in the status of Bill Introduced since June 6, 2023. Bill HR 3840 was introduced during Congress 118 and was introduced to the House on June 6, 2023.  Bill HR 3840's most recent activity was Referred to the Subcommittee on Health. as of June 9, 2023

Bipartisan Support of Bill HR 3840

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 3840

Primary Policy Focus

Health

Comments